loading
前日終値:
$14.26
開ける:
$14.24
24時間の取引高:
49,258
Relative Volume:
0.03
時価総額:
$2.17B
収益:
$113.31M
当期純損益:
$-57.51M
株価収益率:
-10.49
EPS:
-1.36
ネットキャッシュフロー:
$-20.55M
1週間 パフォーマンス:
-5.70%
1か月 パフォーマンス:
-6.39%
6か月 パフォーマンス:
+123.81%
1年 パフォーマンス:
+169.43%
1日の値動き範囲:
Value
$14.14
$14.50
1週間の範囲:
Value
$12.66
$15.27
52週間の値動き範囲:
Value
$3.50
$16.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Name
名前
Wave Life Sciences Ltd
Name
セクター
Healthcare (1195)
Name
電話
617-949-2900
Name
住所
7 STRAITS VIEW, SINGAPORE
Name
職員
268
Name
Twitter
@WAVELifeSci
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
WVE's Discussions on Twitter

WVE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
WVE 14.18 2.17B 113.31M -57.51M -20.55M -1.36
VRTX 447.13 115.74B 10.63B -479.80M -1.35B 13.33
REGN 741.99 81.65B 13.85B 4.65B 3.32B 35.06
ARGX 590.16 34.86B 1.86B -40.29M -1.28B -4.16
ALNY 249.68 32.09B 2.09B -332.26M 16.06M -4.14
BNTX 102.55 24.49B 3.30B -501.07M 1.03B 11.54

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-09-27 再開されました JP Morgan Overweight
2024-09-19 開始されました B. Riley Securities Buy
2024-09-09 開始されました JP Morgan Overweight
2024-05-15 開始されました Wells Fargo Overweight
2023-12-19 アップグレード Leerink Partners Market Perform → Outperform
2023-07-05 開始されました Raymond James Outperform
2023-05-24 ダウングレード Jefferies Buy → Hold
2020-12-15 再開されました H.C. Wainwright Buy
2020-10-23 開始されました RBC Capital Mkts Sector Perform
2019-12-31 ダウングレード SVB Leerink Outperform → Mkt Perform
2019-11-01 開始されました Guggenheim Buy
2019-07-15 開始されました Cowen Market Perform
2019-04-17 繰り返されました H.C. Wainwright Buy
2018-08-07 開始されました Stifel Buy
2018-07-23 開始されました H.C. Wainwright Buy
2018-03-19 繰り返されました Mizuho Buy
2017-02-15 開始されました H.C. Wainwright Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-12-07 開始されました JMP Securities Mkt Outperform
2015-12-07 開始されました Jefferies Buy
2015-12-07 開始されました Leerink Partners Outperform
2015-12-07 開始されました Sun Trust Rbsn Humphrey Buy
すべてを表示

Wave Life Sciences Ltd (WVE) 最新ニュース

pulisher
Nov 20, 2024

Wave Life Sciences Advances RNA Medicine Innovations - TipRanks

Nov 20, 2024
pulisher
Nov 18, 2024

B. Riley Cuts Earnings Estimates for Wave Life Sciences - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Has Pessimistic Outlook of WVE FY2024 Earnings - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Trading (WVE) With Integrated Risk Controls - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 17, 2024

Insider Sale: President and CEO Paul Bolno Sells 51,234 Shares o - GuruFocus.com

Nov 17, 2024
pulisher
Nov 16, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) CEO Sells $733,670.88 in Stock - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 15, 2024

Wave Life Sciences CEO Paul Bolno sells shares for $733,670 - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

WVEWave Life Sciences Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan

Nov 15, 2024
pulisher
Nov 15, 2024

What is HC Wainwright's Forecast for WVE FY2028 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

Wave Life Sciences to Present at Jefferies London Healthcare Conference - The Manila Times

Nov 15, 2024
pulisher
Nov 15, 2024

What is B. Riley's Estimate for WVE Q1 Earnings? - MarketBeat

Nov 15, 2024
pulisher
Nov 15, 2024

US$22.20That's What Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Is Worth After These Results - Simply Wall St

Nov 15, 2024
pulisher
Nov 15, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Released Earnings Last Week And Analysts Lifted Their Price Target To US$22.20 - Yahoo Finance

Nov 15, 2024
pulisher
Nov 15, 2024

Leerink Partnrs Has Bullish Forecast for WVE FY2024 Earnings - MarketBeat

Nov 15, 2024
pulisher
Nov 14, 2024

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St

Nov 14, 2024
pulisher
Nov 14, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Short Interest Update - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

WaVe Life Sciences's SWOT analysis: RNA editing stock faces pivotal year - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 By Investing.com - Investing.com Nigeria

Nov 13, 2024
pulisher
Nov 13, 2024

Wave Life Sciences executive sells shares worth $576,000 - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook By Investing.com - Investing.com Australia

Nov 13, 2024
pulisher
Nov 13, 2024

Alpha-1 Antitrypsin Deficiency Market Expected to Experience Major Growth by 2034, According to DelveInsight | Kamada Pharma, Mereo BioPharma/AstraZeneca, Grifols Therapeutics LLC, Takeda, Vertex - Barchart

Nov 13, 2024
pulisher
Nov 13, 2024

Wave Life Sciences (NASDAQ:WVE) Given "Buy" Rating at HC Wainwright - MarketBeat

Nov 13, 2024
pulisher
Nov 13, 2024

Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024
pulisher
Nov 13, 2024

Earnings call: Wave Life Sciences outlines transformative 2025 outlook - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

WAVE Life Sciences Ltd (WVE) Q3 2024 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance

Nov 13, 2024
pulisher
Nov 12, 2024

Wave Life Sciences’ Q3 2024 Advances in RNA Therapies - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences: Q3 Earnings Snapshot - CT Insider

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences Ltd earnings missed by $0.19, revenue fell short of estimates - Investing.com Nigeria

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences price target raised to $36 from $17 at Truist - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences (WVE) Reports Q3 Loss, Lags Revenue Estimates - MSN

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences files automatic mixed securities shelf - TipRanks

Nov 12, 2024
pulisher
Nov 12, 2024

Q3 2024 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024
pulisher
Nov 12, 2024

Wave Life Sciences Achieves First-Ever Human RNA Editing, Reports $310.9M Cash Position | WVE Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 11, 2024

WAVE Life Sciences Ltd (WVE) Q3 2024: Everything You Need to Kno - GuruFocus.com

Nov 11, 2024
pulisher
Nov 10, 2024

Privium Fund Management B.V. Purchases Shares of 48,834 Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Wave Life Sciences (NASDAQ:WVE) Reaches New 12-Month HighStill a Buy? - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Optimistic Investors Push Wave Life Sciences Ltd. (NASDAQ:WVE) Shares Up 95% But Growth Is Lacking - Simply Wall St

Nov 09, 2024
pulisher
Nov 08, 2024

WVE stock surges to 52-week high, touches $15.99 amid robust gains - Investing.com Australia

Nov 08, 2024
pulisher
Nov 08, 2024

Wave Life Sciences treatment of Huntington’s disease gets FDA orphan designation - TipRanks

Nov 08, 2024
pulisher
Nov 06, 2024

(WVE) On The My Stocks Page - Stock Traders Daily

Nov 06, 2024
pulisher
Nov 05, 2024

Wave Life Sciences (WVE) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat

Nov 05, 2024
pulisher
Nov 05, 2024

Wave Life Sciences (WVE) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Nov 05, 2024
pulisher
Nov 04, 2024

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 - StockTitan

Nov 04, 2024
pulisher
Nov 04, 2024

B. Riley Issues Positive Forecast for Wave Life Sciences (NASDAQ:WVE) Stock Price - MarketBeat

Nov 04, 2024
pulisher
Nov 03, 2024

Institutional investors in Wave Life Sciences Ltd. (NASDAQ:WVE) see US$94m decrease in market cap last week, although long-term gains have benefitted them. - Yahoo Finance

Nov 03, 2024
pulisher
Nov 03, 2024

Emerald Advisers LLC Boosts Stake in Wave Life Sciences Ltd. (NASDAQ:WVE) - MarketBeat

Nov 03, 2024

Wave Life Sciences Ltd (WVE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$70.68
price down icon 0.42%
$18.62
price up icon 0.16%
$36.06
price down icon 1.68%
$364.60
price up icon 0.01%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
大文字化:     |  ボリューム (24 時間):